April 29 (Reuters) - Entrada Therapeutics Inc TRDA.O:
ENTRADA THERAPEUTICS INC - APPROVES STRATEGIC PLAN FOCUSING ON DMD PROGRAMS - SEC FILING
ENTRADA THERAPEUTICS INC - TO REDUCE WORKFORCE BY APPROXIMATELY 20% UNDER NEW PLAN - SEC FILING
ENTRADA THERAPEUTICS INC - EXPECTS CASH RUNWAY TO EXTEND INTO Q2 2027 - SEC FILING
Source text: [ID:n0001104659-25-041204]
Further company coverage: TRDA.O
((Reuters.Briefs@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.